ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komai, H.
Right arrow Articles by Haworth, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komai, H.
Right arrow Articles by Haworth, S. G.

The Annals of Thoracic Surgery, Vol 58, 478-482, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140

H Komai and SG Haworth
Vascular Biology and Pharmacology Unit, Institute of Child Health, London, England.

Soluble GMP-140 can prevent the adhesion of activated neutrophils to endothelium in vitro. Because cardiopulmonary bypass causes neutrophil- endothelial interaction, the plasma level of soluble GMP-140 was measured using an enzyme immunoassay system in 32 children undergoing intracardiac repair of congenital heart disease. They had either a high, low, or normal pulmonary blood flow (n = 13, 12, and 7 respectively). Because activated platelets are a source of GMP-140, the plasma beta-thromboglobulin level was also measured. Blood was sampled before, during, and for 24 hours after cardiopulmonary bypass. Plasma levels of both soluble GMP-140 and beta-thromboglobulin increased after the onset of cardiopulmonary bypass in all patients but for both substances the increase was greater in those with a low pulmonary blood flow (p < 0.05 for all comparisons). The sum total of soluble GMP-140 values during and after operation was correlated negatively with the preoperative mean pulmonary arterial pressure (p < 0.05 for all time intervals). GMP-140 level correlated with the plasma beta- thromboglobulin level (r = 0.5, p < 0.05). This work supports the contention that soluble GMP-140 is released from activated platelets during cardiopulmonary bypass, the level being particularly high in those who had intrinsically abnormal platelets preoperatively in association with a low pulmonary blood flow. Patients with a high pulmonary blood flow, who are more susceptible to endothelial cell injury, may be less well protected by soluble GMP-140.


This article has been cited by other articles:


Home page
PerfusionHome page
H. Komai, Y. Naito, and Y. Okamura
Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery
Perfusion, March 1, 2005; 20(2): 77 - 82.
[Abstract] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. P Vallely, P. G Bannon, C. F Hughes, and L. Kritharides
Endothelial Cell Adhesion Molecules and Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Niimi, F. Ichinose, Y. Ishiguro, K. Terui, S. Uezono, S. Morita, and S. Yamane
The Effects of Heparin Coating of Oxygenator Fibers on Platelet Adhesion and Protein Adsorption
Anesth. Analg., September 1, 1999; 89(3): 573 - 573.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. R. Smith and T. B. Spanier
Aprotinin in deep hypothermic circulatory arrest
Ann. Thorac. Surg., July 1, 1999; 68(1): 278 - 286.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Asimakopoulos and K. M. Taylor
Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
Ann. Thorac. Surg., December 1, 1998; 66(6): 2135 - 2144.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Weerasinghe and K. M. Taylor
The platelet in cardiopulmonary bypass
Ann. Thorac. Surg., December 1, 1998; 66(6): 2145 - 2152.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
H. Komai, Y. Naito, K. Fujiwara, Y. Takagaki, Y. Noguchi, and Y. Nishimura
The protective effect of a leucocyte removal filter on the lung in open-heart surgery for ventricular septal defect
Perfusion, January 1, 1998; 13(1): 27 - 34.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren
LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.